Clinical trials recruiting for Patients With Non-Small Cell Lung Cancer
Fewer than 3 recruiting trials found.
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Docetaxel | 1 |
| OSE2101 | 1 |
| RT (5x6 Gy) to the primary tumor and, if indicated, to lymph node and/or distant metastases. | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| California | 1 |
| Colorado | 1 |
| Connecticut | 1 |
| District of Columbia | 1 |
| Florida | 1 |
| Illinois | 1 |
| Kansas | 1 |
| Louisiana | 1 |
| Maryland | 1 |
| Massachusetts | 1 |
| Nebraska | 1 |
| New York | 1 |
Top cities
Self-screener
Recruiting trials
- Feasibility of Primer Shot Radiotherapy for Non-small Cell Lung Cancer - PRIMER
- Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor
Related conditions
Trials recruiting for Patients With Non-Small Cell Lung Cancer often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Patients With Non-Small Cell Lung Cancer trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.